120 related articles for article (PubMed ID: 31723101)
1. Characteristics of subcutaneous tissues at the site of insertion of peripheral infusion in patients undergoing paclitaxel and carboplatin chemotherapy.
Murayama R; Oya M; Abe-Doi M; Oe M; Komiyama C; Sanada H
Drug Discov Ther; 2019; 13(5):288-293. PubMed ID: 31723101
[TBL] [Abstract][Full Text] [Related]
2. Continuous thermographic observation may predict extravasation in chemotherapy-treated patients.
Oya M; Murayama R; Oe M; Yabunaka K; Tanabe H; Takahashi T; Matsui Y; Otomo E; Komiyama C; Sanada H
Eur J Oncol Nurs; 2017 Jun; 28():56-61. PubMed ID: 28478856
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic assessment of an induration caused by extravasation of a nonvesicant anticancer drug: A case report.
Abe-Doi M; Murayama R; Yabunaka K; Tanabe H; Komiyama C; Sanada H
Medicine (Baltimore); 2019 Apr; 98(14):e15043. PubMed ID: 30946347
[TBL] [Abstract][Full Text] [Related]
4. [Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients].
Nagao S; Okimoto N; Hongo A; Mizutani Y; Kodama J; Yoshinouchi M; Hiramatsu Y; Kudo T
Gan To Kagaku Ryoho; 2003 Feb; 30(2):243-9. PubMed ID: 12610873
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer.
Nagao S; Fujiwara K; Ohishi R; Nakanishi Y; Iwasa N; Shimizu M; Goto T; Shimoya K
Int J Gynecol Cancer; 2008; 18(6):1210-4. PubMed ID: 18284454
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
[TBL] [Abstract][Full Text] [Related]
8. Severe necrosis due to paclitaxel extravasation.
Herrington JD; Figueroa JA
Pharmacotherapy; 1997; 17(1):163-5. PubMed ID: 9017777
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a thermosensitive liquid crystal film for catheterization site assessment immediately following chemotherapy administration: An observational study.
Abe-Doi M; Murayama R; Tanabe H; Komiyama C; Sanada H
Eur J Oncol Nurs; 2020 Oct; 48():101802. PubMed ID: 32942231
[TBL] [Abstract][Full Text] [Related]
10. A feasibility study of paclitaxel 225 mg/m(2) and carboplatin AUC = 6 in untreated advanced non-small cell lung cancer patients in Japan.
Ogawara M; Kawahara M; Hosoe S; Atagi S; Kawaguchi T; Okishio K; Naka N; Sunami T; Mitsuoka S; Inoue K; Haryu H; Yoneda T; Origasa H
Jpn J Clin Oncol; 2002 Feb; 32(2):48-53. PubMed ID: 11948228
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
Johnson DH; Paul DM; Hande KR; DeVore R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
[TBL] [Abstract][Full Text] [Related]
13. A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer.
Akiyama Y; Ohe Y; Tamura T; Sawada M; Inoue A; Kusaba H; Yamamoto N; Sekine I; Kunitoh H; Kodama T; Saijo N
Jpn J Clin Oncol; 2001 Oct; 31(10):482-7. PubMed ID: 11696617
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer.
Meerpohl HG; du Bois A; Kühnle H; Lück HJ; Kreienberg R; Möbus V; Bauknecht T; Köchli O; Bochtler H; Diergarten K
Semin Oncol; 1995 Dec; 22(6 Suppl 15):7-12. PubMed ID: 8643973
[TBL] [Abstract][Full Text] [Related]
15. Damage to subcutaneous tissue at the catheterization site during chemotherapy: A prospective observational study using ultrasonography.
Abe-Doi M; Murayama R; Kawamoto A; Komiyama C; Doorenbos A; Sanada H
Jpn J Nurs Sci; 2021 Oct; 18(4):e12436. PubMed ID: 34350702
[TBL] [Abstract][Full Text] [Related]
16. A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.
Dunphy FR; Boyd JH; Kim HJ; Dunphy CH; Harrison BR; Dunleavy TL; Rodriguez JJ; McDonough EM; Minster JR; Hilton JG
Cancer; 1997 May; 79(10):2016-23. PubMed ID: 9149030
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S
Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935
[TBL] [Abstract][Full Text] [Related]
18. [Laparoscopic peritoneal dialysis catheter implantation in peritoneal chemotherapy for gastric cancer with peritoneal metastasis].
Ma JJ; Zang L; Yang ZY; Xie BW; Hong XZ; Cai ZH; Zhang LY; Yan C; Zhu ZG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):774-780. PubMed ID: 31422617
[No Abstract] [Full Text] [Related]
19. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.
Neijt JP; Engelholm SA; Tuxen MK; Sorensen PG; Hansen M; Sessa C; de Swart CA; Hirsch FR; Lund B; van Houwelingen HC
J Clin Oncol; 2000 Sep; 18(17):3084-92. PubMed ID: 10963636
[TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer.
Huizing MT; van Warmerdam LJ; Rosing H; Schaefers MC; Lai A; Helmerhorst TJ; Veenhof CH; Birkhofer MJ; Rodenhuis S; Beijnen JH; ten Bokkel Huinink WW
J Clin Oncol; 1997 May; 15(5):1953-64. PubMed ID: 9164207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
